Brunel University Research Archive(BURA) preserves and enables easy and open access to all
types of digital content. It showcases Brunel's research outputs.
Research contained within BURA is open access, although some publications may be subject
to publisher imposed embargoes. All awarded PhD theses are also archived on BURA.
Browsing by Author Cliff, JM
Showing results 1 to 13 of 13
| Issue Date | Title | Author(s) |
|---|---|---|
| 28-Jan-2022 | A Natural History of Disease Framework for Improving the Prevention, Management, and Research on Post-viral Fatigue Syndrome and Other Forms of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome | O'Boyle, S; Nacul, L; Nacul, FE; Mudie, K; Kingdon, CC; Cliff, JM; Clark, TG; Dockrell, HM; Lacerda, EM |
| 13-Jul-2023 | Association analysis between symptomology and herpesvirus IgG antibody concentrations in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and multiple sclerosis | Malato, J; Grabowska, AD; Lee, J-S; Ameijeiras-Alonso, J; Biecek, P; Graça, L; Mouriño, H; Scheibenbogen, C; Westermeier, F; Nacul, L; Cliff, JM; Lacerda, E; Sepúlveda, N |
| 1-Dec-2020 | Blood transcriptomics to characterize key biological pathways and identify biomarkers for predicting mortality in melioidosis | Yimthin, T; Cliff, JM; Phunpang, R; Ekchariyawat, P; Kaewarpai, T; Lee, JS; Eckold, C; Andrada, M; Thiansukhon, E; Tanwisaid, K; Chuananont, S; Morakot, C; Sangsa, N; Silakun, W; Chayangsu, S; Buasi, N; Day, N; Lertmemongkolchai, G; Chantratita, W; Eoin West, T; Chantratita, N |
| 16-Apr-2019 | Cellular immune function in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) | Cliff, JM; King, EC; Lee, JS; Sepúlveda, N; Wolf, AS; Kingdon, C; Bowman, E; Dockrell, HM; Nacul, L; Lacerda, E; Riley, EM |
| 31-Jan-2022 | Concurrent evaluation of cytokines improves the accuracy of antibodies against Mycobacterium tuberculosis antigens in the diagnosis of active tuberculosis | Jacobs, R; Awoniyi, DO; Baumann, R; Stanley, K; McAnda, S; Kaempfer, S; Malherbe, ST; Singh, M; Walzl, G; Chegou, NN; Walzl, G; Chegou, NN; Kriel, M; van der Spuy, G; Loxton, AG; Stanley, K; Malherbe, ST; Kriel, B; Sutherland, JS; Owolabi, O; Sillah, A; Mendy, J; Gindeh, A; Donkor, S; Togun, T; Ota, M; Crampin, AC; Simukonda, F; Amberbir, A; Chilongo, F; Houben, R; Kassa, D; Gebrezgeabher, A; Mesfin, G; Belay, Y; Gebremichael, G; Alemayehu, Y; van der Vyver, M; Amutenya, FN; Nelongo, JN; Monye, L; Sheehama, JA; Iipinge, S; Mayanja-Kizza, H; Namuganga, AR; Muzanye, G; Nsereko, M; Peters, P; Howe, R; Mihret, A; Bekele, Y; Tessema, B; Yamuah, L; Ottenhoff, THM; Geluk, A; Franken, K; van der Ploeg-van Schip, JJ; Corstjens, PLAM; Tjon Kon Fat, EM; de Dood, CJ; Rosenkrands, I; Aagaard, C; Kaufmann, SHE; Esterhuyse, MM; Cliff, JM; Dockrell, HM |
| 7-Sep-2015 | Excessive cytolytic responses predict tuberculosis relapse after apparently successful treatment | Cliff, JM; Cho, JE; Lee, JS; Ronacher, K; King, EC; Van Helden, P; Walzl, G; Dockrell, HM |
| 5-Jul-2021 | Herpesviruses Serology Distinguishes Different Subgroups of Patients From the United Kingdom Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Biobank | Domingues, TD; Grabowska, AD; Lee, JS; Ameijeiras-Alonso, J; Westermeier, F; Scheibenbogen, C; Cliff, JM; Nacul, L; Lacerda, EM; Mouriño, H; Sepúlveda, N |
| 28-Nov-2020 | Host transcriptional response to TB preventive therapy differentiates two sub-groups of IGRA-positive individuals | Broderick, C; Cliff, JM; Lee, JS; Kaforou, M; Moore, DA |
| 11-Aug-2020 | How Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Progresses: The Natural History of ME/CFS | Nacul, L; O'Boyle, S; Palla, L; Nacul, FE; Mudie, K; Kingdon, CC; Cliff, JM; Clark, TG; Dockrell, HM; Lacerda, EM |
| 13-Jun-2020 | Impact of Intermediate Hyperglycemia and Diabetes on Immune Dysfunction in Tuberculosis | Eckold, C; Kumar, V; Weiner, J; Alisjahbana, B; Riza, A-L; Ronacher, K; Coronel, J; Kerry-Barnard, S; Malherbe, ST; Kleynhans, L; Stanley, K; Soeroto, A; Permana, H; Imaculata, S; Apriani, L; Ugarte-Gil, C; Walzl, G; van Crevel, R; Wijmenga, C; Critchley, JA; Dockrell, HM; Haks, M; Cliff, JM; Malherbe, S; Dockrell, H; Cliff, J; Eckold, C; Moore, D; Griffiths, U; Laurence, Y; Aarnouste, R; Netea, M; Walzl, G; van Crevel, R; Ruesen, C; Kleynhans, L; Lachmandas, E; Kaufmann, S; Beigier, M; Golinski, R; Joosten, S; Ottenhoff, T; Vrieling, F; Ronacher, K; Smith, B; Stanley, K; van der Spuy, G; Loxton, A; Chegou, N; Bosman, M; Thiart, L; Nitu, F; Wagman, C; Editoiu, C; Tshivhula, H; Selamolela, M; Prins, N; du Plessis, W; van Rensburg, I; du Toit, L; Critchley, J; Kerry-Barnard, S; Bazavan, I; Pearson, F; Grint, D; Florescu, A; McAllister, S; Hill, P; Verrall, A; Ioana, M; Riza, A; Cioboata, R; Dudau, M; Olteanu, M; Mota, M; Popa, SG; Firanescu, A; Popa, A; Gheonea, I; Bicuti, S; Lepadat, A; Capitanescu, I; Vladu, I; Papurica, M; Clenciu, D; Bicu, M; Streba, C; Demetrian, A; Ciurea, M; Cimpoeru, A; Ciocoiu, A; Dorobantu, S; Olaru, M; Plesea, R; Popescu, EL; Valutanu, I; Cucu, M; Streata, I; Burada, F; Serban-Sosoi, S; Panduru, N; Nicoli, E; Ciontea, M; Tataru, T; Dubreu, V; Stamatoiu, L; Kumar, V; Wijmenga, C; Ugarte-Gil, C; Coronel, J; Lopez, S; Gunawan, Y; Limascca, R; Ruslami, R; Villaizan, K; Castro, B; Flores, J; Solano, W; Alisjahbana, B; Ruslami, R; Soetedjo, N; Santoso, P; Dewi, N; Chaidir, L; Koesoemadinata, R; Ioana, M; Susilawati, N; Annisa, J; Livia, R; Yunivita, V |
| 10-Apr-2021 | Mycobacterium tuberculosis-stimulated whole blood culture to detect host biosignatures for tuberculosis treatment response | Cilliers, K; Menezes, A; Webber, T; Dockrell, HM; Cliff, JM; Kleynhans, L; Chegou, NN; du Plessis, N; Loxton, AG; Kidd, M; Djoba Siawaya, JF; Ronacher, K; Walzl, G |
| 6-Aug-2021 | Salivary DNA Loads for Human Herpesviruses 6 and 7 Are Correlated With Disease Phenotype in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome | Lee, JS; Lacerda, EM; Nacul, L; Kingdon, CC; Norris, J; O'Boyle, S; Roberts, CH; Palla, L; Riley, EM; Cliff, JM |
| 15-Jul-2022 | Transcriptional profiles predict treatment outcome in patients with tuberculosis and diabetes at diagnosis and at two weeks after initiation of anti-tuberculosis treatment | van Doorn, CLR; Eckold, C; Ronacher, K; Ruslami, R; van Veen, S; Lee, JS; Kumar, V; Kerry-Barnard, S; Malherbe, ST; Kleynhans, L; Stanley, K; Hill, PC; Joosten, SA; van Crevel, R; Wijmenga, C; Critchley, JA; Walzl, G; Alisjahbana, B; Haks, MC; Dockrell, HM; Ottenhoff, THM; Vianello, E; Cliff, JM |